Soviero Asset Management, LP Gilead Sciences, Inc. Transaction History

Soviero Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $6.09 Million - $6.57 Million	-90,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $15.9 Million - $17.3 Million	-250,000 Reduced 73.53%	90,000 $6.2 Million
Q1 2021 Jul 16, 2021	SELL	$60.0 - $68.46 $6 Million - $6.85 Million	-100,000 Reduced 22.73%	340,000 $22 Million
Q4 2020 Jul 16, 2021	BUY	$56.65 - $64.55 $24.9 Million - $28.4 Million	440,000 New	440,000 $25.6 Million

1,884

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Soviero Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Soviero Asset Management, LP with notifications on news.